• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卟啉症中酶和分子缺陷的最新进展。

Update on enzyme and molecular defects in porphyria.

作者信息

Elder G H

机构信息

Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, UK.

出版信息

Photodermatol Photoimmunol Photomed. 1998 Apr;14(2):66-9. doi: 10.1111/j.1600-0781.1998.tb00014.x.

DOI:10.1111/j.1600-0781.1998.tb00014.x
PMID:9638727
Abstract

Each porphyria results from decreased activity of one of the enzymes of haem biosynthesis. The molecular basis of enzyme deficiencies in acute intermittent porphyria (AIP), variegate porphyria (VP) and congenital erythropoietic porphyria (CEP) is outlined. All three conditions show extensive allelic heterogeneity. In the autosomal dominant disorders, AIP and VP, no genotype/phenotype correlations have been demonstrated, and the explanation for their low clinical penetrance remains uncertain. In AIP and VP, mutational analysis is superior to biochemical methods for screening families for latent porphyria. In the autosomal recessive condition, CEP, there is some genotype/phenotype correlation--one common mutation (C73R) being associated with severe disease in homozygotes. Porphyria cutanea tarda (PCT) is not a simple monogenic disorder. Patients appear to have an inherited susceptibility to inactivation of hepatic uroporphyrinogen decarboxylase (UROD) as part of a response to hepatocyte injury by alcohol, HCV and other agents. Inherited factors that, in combination, may predispose to PCT include mutations in the UROD gene, present in about 20% of patients, and the C282Y mutation in the haemochromatosis (HFE) gene.

摘要

每种卟啉病都是由于血红素生物合成过程中一种酶的活性降低所致。本文概述了急性间歇性卟啉病(AIP)、混合型卟啉病(VP)和先天性红细胞生成性卟啉病(CEP)中酶缺乏的分子基础。这三种疾病均表现出广泛的等位基因异质性。在常染色体显性疾病AIP和VP中,尚未证实基因型与表型之间存在相关性,其临床低外显率的原因仍不确定。在AIP和VP中,突变分析在筛查潜在卟啉病家族方面优于生化方法。在常染色体隐性疾病CEP中,存在一些基因型与表型的相关性——一种常见突变(C73R)与纯合子中的严重疾病相关。迟发性皮肤卟啉病(PCT)并非简单的单基因疾病。患者似乎具有遗传性易感性,易导致肝脏尿卟啉原脱羧酶(UROD)失活,这是对酒精、丙型肝炎病毒和其他因素引起的肝细胞损伤的一种反应。可能共同导致PCT的遗传因素包括UROD基因突变(约20%的患者存在该突变)以及血色素沉着症(HFE)基因中的C282Y突变。

相似文献

1
Update on enzyme and molecular defects in porphyria.卟啉症中酶和分子缺陷的最新进展。
Photodermatol Photoimmunol Photomed. 1998 Apr;14(2):66-9. doi: 10.1111/j.1600-0781.1998.tb00014.x.
2
Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.卟啉症遗传学的最新进展:遗传、外显率和分子异质性,包括新的修饰/致病基因。
Mol Genet Metab. 2019 Nov;128(3):320-331. doi: 10.1016/j.ymgme.2018.11.012. Epub 2018 Nov 30.
3
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.迟发性皮肤卟啉病和肝红细胞生成性卟啉病:19 种新型尿卟啉原 III 脱羧酶突变的鉴定。
Mol Genet Metab. 2019 Nov;128(3):363-366. doi: 10.1016/j.ymgme.2018.11.013. Epub 2018 Nov 28.
4
Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.意大利卟啉病的分子特征:诊断流程图
Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.
5
Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.人类卟啉症的鼠模型:对疾病发病机制的理解和新疗法的发展的贡献。
Mol Genet Metab. 2019 Nov;128(3):332-341. doi: 10.1016/j.ymgme.2019.01.007. Epub 2019 Jan 18.
6
Heme biosynthesis and the porphyrias.血红素生物合成与卟啉病。
Mol Genet Metab. 2019 Nov;128(3):164-177. doi: 10.1016/j.ymgme.2019.04.008. Epub 2019 Apr 22.
7
New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda.双卟啉症的新形式:急性间歇性卟啉症与迟发性皮肤卟啉症并存。
Eur J Clin Invest. 1989 Feb;19(1):20-5. doi: 10.1111/j.1365-2362.1989.tb00190.x.
8
Hepatic porphyrias in children.儿童肝性卟啉病
J Inherit Metab Dis. 1997 Jun;20(2):237-46. doi: 10.1023/a:1005313024076.
9
Porphyrias in Japan: compilation of all cases reported through 2002.日本的卟啉病:截至2002年报告的所有病例汇编。
Int J Hematol. 2004 Jun;79(5):448-56. doi: 10.1532/ijh97.03127.
10
Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.人类尿卟啉原脱羧酶缺陷的遗传学与发病机制
Clin Biochem. 1989 Jun;22(3):163-8. doi: 10.1016/s0009-9120(89)80072-4.

引用本文的文献

1
Cutaneous manifestations of hepatitis C in the era of new antiviral agents.新型抗病毒药物时代丙型肝炎的皮肤表现
World J Hepatol. 2015 Nov 28;7(27):2740-8. doi: 10.4254/wjh.v7.i27.2740.